Wolfram Bode was a researcher affiliated with the Max Planck Society in Germany. Their main field of study was Biochemistry, Genetics and Molecular Biology, with a subfocus on Genetics. The scientist's research contributed topics related to virus-based gene therapy research.
Bode's recent publication includes the paper titled Changing Residue 338 in Human Factor IX from Arginine to Alanine Causes an Increase in Catalytic Activity, published in 2021 in UNC Libraries.
The scientist frequently collaborated with several researchers, including:
Their scientific contributions were published in venues such as:
W Bode;I Mayr;U Baumann;R Huber
Vito Turk;Wolfram Bode
Wolfram Bode;Franz-Xaver Gomis-Rüth;Walter Stöckler
Timothy J. Rydel;K. G. Ravichandran;A. Tulinsky;Wolfram Bode
Robert Huber;Wolfram Bode
Albrecht Messerschmidt;R. Huber;Thomas Poulos;Karl Wieghardt
W. Stöcker;F. Grams;U. Baumann;P. Reinemer
Wolfram Bode;Dusan Turk;Andrej Karshikov
M. Marquart;J. Walter;J. Deisenhofer;W. Bode
W. Bode;R. Engh;D. Musil;U. Thiele
Franz-Xaver Gomis-Rüth;Klaus Maskos;Michael Betz;Andreas Bergner
M T Stubbs;B Laber;W Bode;R Huber
Wolfram Bode;Peter Schwager
Milton T. Stubbs;Milton T. Stubbs;Wolfram Bode;Wolfram Bode
Kaillathe Padmanabhan;K.P. Padmanabhan;A. Tulinsky;Chang H. Park
Wolfram Bode;Edgar Meyer;James C. Powers
Timothy J. Rydel;Alexander Tulinsky;Wolfram Bode;Robert Huber
M. G. Grütter;J. P. Priestle;J. Rahuel;H. Grossenbacher
Tilman Schirmer;Wolfram Bode;Robert Huber;Walter Sidler
Klaus Maskos;Carlos Fernandez-Catalan;Robert Huber;Gleb P. Bourenkov
If you think any of the details on this page are incorrect, let us know.